Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 66.64B 9.94B 8.82B 8.26B 7.48B 14.13B 958B 14.24B 99.17B 38.57B 489B 37.31B 36.51B 1,571B | P/E 2026 * |
50.2x | P/E 2027 * | 37.9x |
|---|---|---|---|---|---|
| Enterprise Value | 61.97B 9.24B 8.2B 7.68B 6.96B 13.14B 891B 13.24B 92.22B 35.87B 455B 34.69B 33.95B 1,461B | EV / Sales 2026 * |
7.66x | EV / Sales 2027 * | 6.43x |
| Free-Float |
62.13% | Yield 2026 * |
0.72% | Yield 2027 * | 0.96% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 9.94B | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,032B | |
| +0.73% | -4.78% | +35.41% | +61.62% | 614B | |
| +0.35% | +1.29% | +15.86% | +79.90% | 471B | |
| +1.72% | -4.92% | +59.84% | +36.64% | 350B | |
| +0.26% | +0.14% | +21.29% | +40.99% | 337B | |
| +0.60% | -3.09% | +10.76% | +32.59% | 268B | |
| +1.65% | -3.78% | -6.03% | +9.29% | 246B | |
| -0.09% | -4.97% | +36.88% | +50.52% | 218B | |
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | |
| Average | +0.34% | -3.71% | +26.44% | +56.59% | 412.76B | |
| Weighted average by Cap. | +0.05% | -3.43% | +29.54% | +67.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.21B 1.07B 1B 908M 1.72B 116B 1.73B 12.04B 4.68B 59.33B 4.53B 4.43B 191B | 9.8B 1.46B 1.3B 1.21B 1.1B 2.08B 141B 2.09B 14.59B 5.67B 71.9B 5.49B 5.37B 231B |
| Net income | 1.41B 211M 187M 175M 159M 299M 20.3B 302M 2.1B 817M 10.35B 790M 773M 33.29B | 1.82B 271M 241M 225M 204M 385M 26.13B 388M 2.7B 1.05B 13.33B 1.02B 996M 42.86B |
| Net Debt | -4.67B -697M -619M -579M -525M -991M -67.19B -998M -6.95B -2.7B -34.28B -2.62B -2.56B -110B | -3.66B -545M -484M -453M -411M -775M -52.56B -781M -5.44B -2.12B -26.81B -2.05B -2B -86.2B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
